Dr. Mizrachi received his medical degree from the Hebrew University and Hadassah Medical School in Jerusalem and then completed a residency in Otolaryngology-Head and Neck Surgery at Rabin Medical Center, a leading tertiary care center in Israel, which is also the largest cancer center in the country serving a population of approximately 4.5 million people. Following that, Dr. Mizrachi pursued advanced training in head and neck oncologic surgery and translational research at Memorial Sloan-Kettering Cancer Center in New York.

After completing his fellowship, Dr. Mizrachi returned to Rabin Medical Center and practiced there as a full-time surgeon-scientist for 8 years before moving back to NY.

Dr. Mizrachi's research portfolio focuses on precision oncology, investigating tumor and radiation biology and immunology as well as targeted drug delivery for Head and Neck Cancer and Skin Cancer.

Dr. Mizrachi is a member of the American Association for Cancer Research, American Head and Neck Society, International Federation of Head and Neck Oncologic Societies, and the American College of Surgeons. He is the author of over 85 peer-reviewed publications and is often invited to speak at national and international professional meetings.